<DOC>
	<DOCNO>NCT00927719</DOCNO>
	<brief_summary>This enhance safety surveillance study occur within military Service Member population . Primary Objective : - To evaluate rate suspect , probable , confirm myocarditis and/or pericarditis temporal association ACAM2000® vaccination . Secondary Objectives : - To evaluate rate cardiovascular adverse event temporal association ACAM2000® vaccination . - To evaluate rate neurological adverse event temporal association ACAM2000® vaccination .</brief_summary>
	<brief_title>Safety Surveillance Study ACAM2000® Vaccinia Vaccine</brief_title>
	<detailed_description>The Armed Forces Health Surveillance Activity ( AFHSA ) perform comprehensive health surveillance operation Defense Medical Surveillance System ( DMSS ) . Demographic medical information gather within monthly report DMSS collect approximately 100,000 200,000 military Service Members receive ACAM2000® smallpox vaccine .</detailed_description>
	<mesh_term>Smallpox</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Male female military personnel &gt; = 17 year age . Have receive ACAM2000® smallpox vaccine . Exclusion Criteria :</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Smallpox</keyword>
	<keyword>Smallpox Vaccine</keyword>
	<keyword>Vaccinia virus</keyword>
	<keyword>Military</keyword>
</DOC>